Glia maturation factor-gamma modulation of signaling pathways in macrophages

巨噬细胞信号通路的神经胶质成熟因子-γ调节

基本信息

项目摘要

Monocyte migration requires the dynamic redistribution of integrins through a regulated endo-exocytosis cycle, but the complex molecular mechanisms underlying this process have not been fully elucidated. Glia maturation factor- (GMFG), a novel regulator of the Arp2/3 complex, has been shown to regulate directional migration of neutrophils and T-lymphocytes. In this study, we explored the important role of GMFG in monocyte chemotaxis, adhesion, and 1-integrin turnover. We found that knockdown of GMFG in monocytes resulted in impaired chemotactic migration toward formyl-Met-Leu-Phe (fMLP) and stromal cell-derived factor 1 (SDF-1) as well as decreased 51-integrin-mediated chemoattractant-stimulated adhesion. These GMFG knockdown impaired effects could be reversed by cotransfection of GFP-tagged full-length GMFG. GMFG knockdown cells reduced the cell surface and total protein levels of 51-integrin and increased its degradation. Importantly, we demonstrate that GMFG mediates the ubiquitination of 1-integrin through knockdown or overexpression of GMFG. Moreover, GMFG knockdown retarded the efficient recycling of 1-integrin back to the plasma membrane following normal endocytosis of 51-integrin, suggesting that the involvement of GMFG in maintaining 51-integrin stability may occur in part by preventing ubiquitin-mediated degradation and promoting 1-integrin recycling. Furthermore, we observed that GMFG interacted with syntaxin 4 (STX4) and syntaxin-binding protein 4 (STXBP4); however, only knockdown of STXBP4, but not STX4, reduced monocyte migration and decreased 1-integrin cell surface expression. Knockdown of STXBP4 also substantially inhibited 1-integrin recycling in human monocytes. These results indicate that the effects of GMFG on monocyte migration and adhesion probably occur through preventing ubiquitin-mediated proteasome degradation of 51-integrin and facilitating effective 1-integrin recycling back to the plasma membrane.
单核细胞迁移需要通过受调节的胞吐循环动态重新分配整合素,但这一过程背后的复杂分子机制尚未完全阐明。神经胶质成熟因子 (GMFG) 是 Arp2/3 复合物的一种新型调节剂,已被证明可以调节中性粒细胞和 T 淋巴细胞的定向迁移。在这项研究中,我们探讨了 GMFG 在单核细胞趋化性、粘附性和 1-整合素周转中的重要作用。我们发现,单核细胞中GMFG的敲低导致向甲酰基-Met-Leu-Phe (fMLP)和基质细胞衍生因子1 (SDF-1)的趋化迁移受损,以及51-整合素介导的趋化剂刺激的粘附减少。这些 GMFG 敲低受损效应可以通过 GFP 标记的全长 GMFG 共转染来逆转。 GMFG 敲低细胞降低了细胞表面和 51-整合素总蛋白水平,并增加了其降解。重要的是,我们证明GMFG通过GMFG的敲低或过表达来介导1-整合素的泛素化。此外,GMFG敲低阻碍了51-整合素正常内吞后1-整合素有效回收回质膜,这表明GMFG参与维持51-整合素稳定性可能部分是通过防止泛素介导的降解和促进1-整合素回收来实现的。此外,我们观察到 GMFG 与突触融合蛋白 4 (STX4) 和突触融合蛋白结合蛋白 4 (STXBP4) 相互作用;然而,只有 STXBP4 的敲低(而不是 STX4)会减少单核细胞迁移并减少 1-整合素细胞表面表达。 STXBP4 的敲除也显着抑制了人单核细胞中 1-整合素的再循环。这些结果表明,GMFG 对单核细胞迁移和粘附的影响可能是通过阻止泛素介导的 51-整合素蛋白酶体降解并促进 1-整合素有效回收回质膜而发生的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRIFFIN RODGERS其他文献

GRIFFIN RODGERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRIFFIN RODGERS', 18)}}的其他基金

Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
  • 批准号:
    8939812
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
  • 批准号:
    8557968
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
  • 批准号:
    8557970
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
胶质细胞成熟因子-γ负调节巨噬细胞中的 TLR4 信号传导
  • 批准号:
    8149534
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
  • 批准号:
    8149535
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
  • 批准号:
    9157363
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
  • 批准号:
    8344821
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
  • 批准号:
    8557967
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
  • 批准号:
    8939810
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:
Olfactomedin 4 is a key regulator of human neutrophil function
Olfactomedin 4 是人类中性粒细胞功能的关键调节剂
  • 批准号:
    10012677
  • 财政年份:
  • 资助金额:
    $ 58.81万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.81万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.81万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.81万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 58.81万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 58.81万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 58.81万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 58.81万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 58.81万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 58.81万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 58.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了